Soft tissue sarcomas (STS) represent a heterogeneous group of diverse neoplasms of mesenchymal origin. Once relapsed from standard therapy, STS patients…

Between 15-90% of cancer patients and survivors report some form of insomnia or sleep quality impairment during and post-treatment, such as excessive…

This educational symposium, supported by an unrestricted educational grant from Daiichi Sankyo, was given at the European Society of Cardiology (ESC)…

The current management of patients with hypertension, especially those with a high risk of coronary artery disease should take into account the role of…

Dabigatran, rivaroxaban, apixaban and edoxaban are four new oral anticoagulants (NOACs). There are an increasing number of indications for which these…

This Boehringer Ingelheim sponsored satellite symposium was held on 2nd September 2013 as part of the ESC conference, which was hosted this year in…

Ischaemic/embolic complications are the most common severe consequences of atrial fibrillation. Although chronic anticoagulation with warfarin has been…

Atrial fibrillation (AF) associated with familial hyperthyroidism (FH) spanning three generations concomitantly, is rare. The index case was 10 years old…

An increased risk of coronary heart disease was an immediate healthcare concern following the mass arrival of South Asian immigrants to the UK, and it…

Patients who have been treated for aortic coarctation (CoA) have increased late cardiovascular morbidity and mortality, which is partly due to the…